Back to companies

Ovid Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Ovid Therapeutics Inc (Ovid Therapeutics) is a biopharmaceutical company that develops small molecule therapies for neurological and rare diseases. Its pipeline products include OV329 GABA aminotransferase inhibitor which treats epilepsy and seizures disorders; OV4071 an oral which targets Parkinson’s disease and Lewy body dementia. The company is also developing ROCK2 inhibitor, OV888, to treat cerebral cavernous malformations. It collaborates with pharmaceutical companies and research organizations. Ovid Therapeutics is headquartered in New York, the US.

 Gain a 360-degree view of Ovid Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Ovid Therapeutics Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 14th Floor, 441 9th Avenue, New York City, 10001
Website ovidrx.com
Telephone 1 646 6617661
No of Employees 23
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange OVID (NASD)
Revenue (2024) $7.3M 1181.3% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ 34.1% (2024 vs 2023)
Market Cap* $522.6M
Net Profit Margin (2024) XYZ 94.9% (2024 vs 2023)
* As of and is in US$
View Ovid Therapeutics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products
Pipeline
OV329: Epilepsy and Seizures Disorders
OV4071 oral: Parkinson's Disease and Lewy Body Dementia
XYZ
XYZ
XYZ
Understand Ovid Therapeutics Inc portfolio and identify potential areas for collaboration Understand Ovid Therapeutics Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Ovid Therapeutics Inc Jazz Pharmaceuticals Plc Acadia Pharmaceuticals Inc Harmony Biosciences Holdings Inc Xenon Pharmaceuticals Inc
Headquarters United States of America Ireland United States of America United States of America Canada
City New York City Dublin San Diego Plymouth Meeting Vancouver
State/Province New York Dublin California Pennsylvania British Columbia
No. of Employees 23 2,890 796 293 358
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Jeremy M. Levin Chairman Executive Board 2015 72
Margaret Alexander Director; Chief Executive Officer; President Executive Board 2026 45
Charles Carter Chief Financial Officer Senior Management 2026 -
Meg Alexander Chief Operating Officer; President Senior Management 2024 -
Victoria Fort Chief Strategy Officer Senior Management 2026 -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Ovid Therapeutics Inc key executives to enhance your sales strategy Gain insight into Ovid Therapeutics Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?